Faro Health

Integrated clinical development environment for AI-assisted protocol design and study authoring.

Faro Health, founded in 2019 and headquartered in San Diego, California, provides an integrated clinical development environment that simplifies the design and authoring of complex clinical study protocols, helping teams model study cost, burden, and complexity earlier. The company has raised approximately $38M through a Series B. Faro's own trust center documents SOC 2 Type II attestation (audited annually), ISO 27001:2022 certification, and an ISO 9001:2015 quality management system; its privacy program is described as aligned to GDPR (not a separate certification).

Headquarters
San Diego, United States
Founded
2019
Compliance
SOC 2 Type II, ISO 27001
Deployment options
cloud
Website
https://farohealth.com

Categories

AI Use Cases

  • Protocol Design Optimization

Vendor Scorecard

64% — Partial coverage. Coverage score — how completely Atlas documents Faro Health across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Documented

SOC 2 Type II, ISO 27001

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, R&D Leadership

Solution Scope — Documented

Trial Protocol Optimization

Company Viability — Partially documented

Series B, Founded 2019

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • How does the platform quantify protocol complexity and patient burden for our study types?
  • How does authored protocol content flow into our downstream systems?
  • Can you share the current SOC 2 Type II report and ISO 27001 certificate under NDA?
  • What does a typical onboarding and template configuration look like?